-
Tytuł:
-
Nutraceuticals and Behavioral Therapy for Headache.
-
Autorzy:
-
Barmherzig R; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Rajapakse T; Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada. .; Stollery Children's Hospital, Women & Children's Research Institute, Edmonton, AB, Canada. .
-
Źródło:
-
Current neurology and neuroscience reports [Curr Neurol Neurosci Rep] 2021 May 10; Vol. 21 (7), pp. 33. Date of Electronic Publication: 2021 May 10.
-
Typ publikacji:
-
Journal Article; Review
-
Język:
-
English
-
Imprint Name(s):
-
Original Publication: Philadelphia, PA : Current Science Inc., c2001-
-
MeSH Terms:
-
Acceptance and Commitment Therapy*
Complementary Therapies*
Behavior Therapy ; Dietary Supplements ; Headache/therapy ; Humans
-
Contributed Indexing:
-
Keywords: Behavioral therapy; Complementary and alternative medicine; Headache; Integrative medicine; Migraine; Nutraceuticals
-
Entry Date(s):
-
Date Created: 20210510 Date Completed: 20210520 Latest Revision: 20210604
-
Update Code:
-
20240104
-
DOI:
-
10.1007/s11910-021-01120-3
-
PMID:
-
33970348
-
Purpose of Review: Headache affects and disables at least 1 billion people worldwide. Patients and providers seek new therapies to relieve headache without the side effects and financial burden of current treatments. This narrative review highlights recent treatment advances in integrative headache medicine: nutraceuticals and behavioral therapies.
Recent Findings: Growing use of complementary and alternative medicine (CAM) therapies for headache (riboflavin, coenzyme Q10, magnesium, vitamin D, melatonin) alongside mainstream treatments is increasing with improving evidence of quality, safety, and tolerability. Increasing interest in medical cannabis is tempered by lack of evidence regarding safety and efficacy. Behavioral therapies including cognitive behavioral therapy (CBT), biofeedback, mindfulness-based stress reduction (MBSR), and acceptance and commitment therapy (ACT) improve patient resiliency and self-efficacy outcomes and reduce disability. The body of evidence for nutraceutical and behavioral CAM interventions for headache continues to grow and improve in quality. Providers and patients should educate themselves regarding CAM therapies as part of integrative headache management. Future studies should examine combinatorial trials of CAM therapies against current standards of headache care.
